5-(4-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid;2,2,2-trifluoroacetic acid
C21H13ClF3N3O4 — CID 50942445
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(4-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid;2,2,2-trifluoroacetic acid
5-(4-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid;2,2,2-trifluoroacetic acid (PubChem CID 50942445) has the molecular formula C21H13ClF3N3O4 and a molecular weight of 463.80 g/mol. Its IUPAC name is 5-(4-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 5-(4-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 50942445 |
| Molecular Formula | C21H13ClF3N3O4 |
| Molecular Weight | 463.80 g/mol |
| Exact Mass | 463.05 |
| IUPAC Name | 5-(4-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid;2,2,2-trifluoroacetic acid |
| SMILES | O=C(O)C(F)(F)F.O=C(O)c1ccc2c(c1)nc(Nc1ccc(Cl)cc1)c1ccncc12 |
| InChI | InChI=1S/C19H12ClN3O2.C2HF3O2/c20-12-2-4-13(5-3-12)22-18-15-7-8-21-10-16(15)14-6-1-11(19(24)25)9-17(14)23-18;3-2(4,5)1(6)7/h1-10H,(H,22,23)(H,24,25);(H,6,7) |
| InChIKey | LJDOMNKDNNVPRS-UHFFFAOYSA-N |
| XLogP | 5.51 |
| TPSA | 112.41 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.80 |
| LogP ≤ 5 | 5.51 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 50942445 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.